Biosimilars Links |
Process Development and cGMP Manufacturing StrategyGoodwin Biotechnology will employ a risk-based, QbD approach from the beginning of your project through to the filing of your Investigational New Drug (IND) or Biologics License Application (BLA).
In short, Goodwin Biotechnology will help to:
|
For more information on our biosimilars services please fill out the form below.
|